BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729
150 results:

  • 1. CT radiomics analysis discriminates pulmonary lesions in patients with pulmonary MALT lymphoma and non-pulmonary MALT lymphoma.
    Le Y; Zhu H; Ye C; Lin J; Wang N; Yang T
    Methods; 2024 Apr; 224():54-62. PubMed ID: 38369073
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer.
    Shibaki R; Fujimoto D; Nozawa T; Sano A; Kitamura Y; Fukuoka J; Sato Y; Kijima T; Matsumoto H; Yokoyama T; Miura S; Hata A; Tamiya M; Taniguchi Y; Sugisaka J; Furuya N; Tanaka H; Yamamoto N; Koh Y; Akamatsu H
    J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38360040
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Breaking boundaries in radiology: redefining AI diagnostics via raw data ahead of reconstruction.
    He B; Sun C; Li H; Wang Y; She Y; Zhao M; Fang M; Zhu Y; Wang K; Liu Z; Wei Z; Mu W; Wang S; Tang Z; Wei J; Shao L; Tong L; Huang F; Tang M; Guo Y; Zhang H; Dong D; Chen C; Ma J; Tian J
    Phys Med Biol; 2024 Mar; 69(7):. PubMed ID: 38224617
    [No Abstract]    [Full Text] [Related]  

  • 4. Differential efficacy of tyrosine kinase inhibitors according to the types of EGFR mutations and agents in non-small cell lung cancer: a real-world study.
    Kim TH; Choi JH; Ahn MS; Lee HW; Kang SY; Choi YW; Koh YW; Sheen SS
    BMC Cancer; 2024 Jan; 24(1):70. PubMed ID: 38216948
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Estimation of health-related and economic impacts of PM2.5 in Arak, Iran, using BenMAP-CE.
    Salehi M; Almasi Hashiani A; Karimi B; Mirhoseini SH
    PLoS One; 2023; 18(12):e0295676. PubMed ID: 38127954
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Integrative Multianalytical Model Based on Novel Plasma Protein Biomarkers for Distinguishing lung Adenocarcinoma and Benign Pulmonary Nodules.
    Zhang X; Ji L; Liu M; Li J; Sun H; Liang F; Zhao Y; Wang Z; Yang T; Wang Y; Si Q; Du R; Dai L; Ouyang S
    J Proteome Res; 2024 Jan; 23(1):277-288. PubMed ID: 38085828
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Predicting micropapillary or solid pattern of lung adenocarcinoma with CT-based radiomics, conventional radiographic and clinical features.
    Wang Z; Zhang N; Liu J; Liu J
    Respir Res; 2023 Nov; 24(1):282. PubMed ID: 37964254
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of epithelial-mesenchymal transition-related biomarkers in lung adenocarcinoma using bioinformatics and lab experiments.
    Cheng Y; Shen Y; Fang Q; Duan S; Wang Y; Dai X; Chen Y
    Aging (Albany NY); 2023 Oct; 15(21):11970-11984. PubMed ID: 37910672
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Investigating Causal Effects of Hematologic Traits on lung cancer: A Mendelian Randomization Study.
    Yang Z; He H; He G; Zeng C; Hu Q
    Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):96-105. PubMed ID: 37909945
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Computed Tomography-Guıded Tru-Cut Bıopsy in the Dıagnosıs of lung Lesıons; Our Clınıcal Experience.
    Gurler F; Ozsoy IE; Tezcan MA; Karaman H
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3059-3064. PubMed ID: 37774057
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Using CT imaging features to predict visceral pleural invasion of non-small-cell lung cancer.
    Yang Y; Xie Z; Hu H; Yang G; Zhu X; Yang D; Niu Z; Mao G; Shao M; Wang J
    Clin Radiol; 2023 Dec; 78(12):e909-e917. PubMed ID: 37666721
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Postoperative circulating tumor DNA detection and cblb mutations are prognostic biomarkers for gastric cancer.
    Zhou H; Liu H; Li J; Wang J; Fu X; Li Y; Mao S; Du J
    Genes Genomics; 2023 Aug; 45(8):1037-1046. PubMed ID: 37306927
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A strategy to reduce the false-positive rate after low-dose computed tomography in lung cancer screening: A multicenter prospective cohort study.
    Wu Z; Tan F; Xie Y; Tang W; Wang F; Xu Y; Cao W; Qin C; Dong X; Zheng Y; Luo Z; Wang C; Zhao L; Xia C; Li J; Li R; Feng F; Li J; Ren J; Shi J; Cui H; Shen S; Wu N; Chen W; Li N; He J
    Cancer Med; 2023 Jul; 12(13):14781-14793. PubMed ID: 37199391
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Value of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration to Diagnose the lung Nodules Related Enlarged Mediastinal Lymph Nodes.
    Zhang Y; Li H; Li Z; Lv B; Zhen Q; Zhao X; Zhang B; Geng L
    Altern Ther Health Med; 2023 Jul; 29(5):396-399. PubMed ID: 37171949
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Trends in Survival Rates of Non-Small Cell lung cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020.
    Chi SA; Yu H; Choi YL; Park S; Sun JM; Lee SH; Ahn JS; Ahn MJ; Choi DH; Kim K; Jung HA; Park K
    JAMA Netw Open; 2023 Mar; 6(3):e232002. PubMed ID: 36929402
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Usefulness of pyruvate dehydrogenase-E1α expression to determine SUVmax cut-off value of [
    Ito R; Yashiro M; Tsukioka T; Izumi N; Komatsu H; Inoue H; Nishiyama N
    Sci Rep; 2023 Jan; 13(1):1565. PubMed ID: 36709375
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Radiomics feature analysis and model research for predicting histopathological subtypes of non-small cell lung cancer on CT images: A multi-dataset study.
    Song F; Song X; Feng Y; Fan G; Sun Y; Zhang P; Li J; Liu F; Zhang G
    Med Phys; 2023 Jul; 50(7):4351-4365. PubMed ID: 36682051
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The value of serum TRAP1 in diagnosing small cell lung cancer and tumor immunity.
    Tan LM; Ke SP; Li X; Ouyang TL; Yu LQ; Yu JL; Wang YK; Yang QJ; Li XH; Yu X; Li H; Hu XY
    Exp Biol Med (Maywood); 2023 Feb; 248(3):201-208. PubMed ID: 36598065
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Combined Radiomics-Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell lung cancer.
    Chen W; Wang L; Hou Y; Li L; Chang L; Li Y; Xie K; Qiu L; Mao D; Li W; Xia Y
    Technol Cancer Res Treat; 2022; 21():15330338221142400. PubMed ID: 36476110
    [No Abstract]    [Full Text] [Related]  

  • 20. The Effect of immunotherapy on oligometastatic non-small cell lung cancer patients by sites of metastasis.
    Ma JC; Zhang JX; Wang F; Yu J; Chen D
    Front Immunol; 2022; 13():1039157. PubMed ID: 36451822
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.